FDA News & Prediction Market Coverage
Track the latest FDA news across prediction markets. Prediction News is following 3 active FDA stories across regulation, legal action, market moves, and platform developments, each clustered from original reporting and summarized for operators, traders, and regulators.
Latest News
Frequently Asked Questions
What is the FDA drug approval process?
The FDA evaluates clinical trial data submitted by sponsors to determine whether a drug meets standards for safety and efficacy before granting approval.
How long does FDA drug approval take?
Timelines vary by review pathway and data completeness, with standard reviews typically spanning several months after submission of a complete application.
What information about clinical trials is public?
Certain trial registrations and results are posted on public databases, but material non-public information held by sponsors, investigators, or regulators remains restricted until disclosure.
Can prediction markets on FDA decisions create conflicts of interest?
Yes, markets on trial outcomes and approvals create direct financial incentives for individuals with non-public data, raising insider-trading and research-integrity concerns noted in recent coverage.
Are FDA employees allowed to trade prediction markets?
Federal ethics rules restrict employees from using non-public information for personal financial gain, though enforcement specifics for event contracts remain untested in this context.